Acetylator polymorphism in rheumatoid arthritis.

Abstract excerpt

Acetylator phenotype has been determined with sulphamethazine (sulphadimidine) in 69 Spanish patients with rheumatoid arthritis (48 females), all of whom were on second line therapy, and in 96 age-matched normal controls (54 females). Thirty-two patients (46.4%) and 56 controls (58.3%) were classified as slow acetylators. On analysing separately the females in both groups, 37.5% of patients and 63% of controls...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Arthritis, Rheumatoid
• Share to Case-Control Studies
• Share to Phenotype